Story perspectives

Appeals Court Restores In-Person Mifepristone Rule, Clinics Shift to Misoprostol

5/6/2026

Summary

Story summary

A U.S. federal appeals court reinstated the in-person dispensing requirement for mifepristone, prompting a Supreme Court pause of the rule until May 11.
After the ruling, abortion clinics such as Carafem, Planned Parenthood and HeyJane switched to misoprostol-only medication protocols.
Patients flooded Carafem’s hotline with fear and anger, asking whether the medication remained available.
Plan C reported that about one-third of abortions in early 2025 were obtained via telehealth medication pills.

1 of 1

Story summary

A U.S. federal appeals court reinstated the in-person dispensing requirement for mifepristone, prompting a Supreme Court pause of the rule until May 11.
After the ruling, abortion clinics such as Carafem, Planned Parenthood and HeyJane switched to misoprostol-only medication protocols.
Patients flooded Carafem’s hotline with fear and anger, asking whether the medication remained available.
Plan C reported that about one-third of abortions in early 2025 were obtained via telehealth medication pills.